Janus Kinase Inhibition in Granuloma Annulare
NCT05650736
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Granuloma Annulare
Interventions
DRUG:
Abrocitinib 200 mg
Sponsor
William Damsky
Collaborators
[object Object]
[object Object]